Cell Signaling Technology

Product Pathways - Growth Factors/Cytokines

Interleukin-11 #2168

MW Source Purity
19.1 kDa Human recombinant protein

Description

The human IL-11 coding cDNA was subcloned into an expression vector and expressed in E. coli. The recombinant human IL-11 proteins were purified and stored in PBS buffer containing 0.1% BSA.

Concentration and Specific Activity

100 μg/ml, 5 x 10 (6) IU/mg

Western Blotting

Western Blotting

Western blot analysis of extracts from HT29 cells, untreated or IL-11-stimulated (100 ng/ml for 15 min), using Phospho-Stat3 (Tyr705) (D3A7) Rabbit mAb #9145 (upper) or Stat3 (79D7) Rabbit mAb #4904 (lower).

Directions for Use

CST recommends using 50-100 ng/ml of IL-11 for stimulation of IL-11 signaling.

Background

TBA

Interleukin-11 (IL-11) was initially cloned as a mediator of plasmacytoma cell proliferation and was later found to exhibit a wide variety of biological effects in neural cells as well as in the hematopoietic and immune systems (1). IL-11 belongs to the interleukin-6 (IL-6)-type subfamily of long-chain helical cytokines including IL-6, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M and cardiotrophin-1, which all share the glycoprotein gp130 as a signal transducing receptor component. IL-11 acts on cells expressing gp130 and the IL-11 receptor (IL-11R) α subunit. Both receptor subunits belong to the family of class I cytokine receptors. The complex of IL-11 and IL-11R triggers the activation of gp130 most likely by enforcing gp130 homodimerization (2). As a consequence of gp130 activation several cytoplasmic signal transduction cascades are initiated from which the Janus kinase (Jak)/signal transducer and activator of transcription (Stat) pathway has attracted considerable attention. Initiation of the Jak/Stat pathway in response to IL-11 requires Jak1 and leads predominantly to the activation of Stat3 (3,4).

  1. Du, X. and Williams, D.A. (1997) Blood 89, 3897-3908.
  2. Tacken, I. et al. (1999) Eur. J. Biochem. 265, 645-655.
  3. Dahmen, H. et al. (1998) Biochem J. 331 ( Pt 3), 695-702.
  4. Kiessling, S. et al. (2004) J. Biol. Chem. 279, 10304-10315.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes